Announcements

Latest announcements

ANNOUNCEMENT: Statement re Rule 2.6 Extension

In accordance with Rule 2.6(c) of the Code, at the request of the Directors of Sativa, the Panel on Takeovers & Mergers (the “Panel”) has consented to an extension of the relevant deadline, until 5:00 p.m. on 3 June 2020 to enable the parties to complete the compilation…

ANNOUNCEMENT: Statement regarding possible offer

Sativa Group Plc [NEX: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis Group, confirms that is has today entered into a letter of intent (“LOI”) with StillCanna, Inc, (“StillCanna”), regarding a possible offer for the Company.

StillCanna Inc. is a leader in cannabinoid extraction and agriculture, it is focused on the large-scale manufacturing of CBD in Europe and has built two high volume extraction facilities, positioning itself as a leader in the seed to CBD supply.

ANNOUNCEMENT: Appointment of Peterhouse Capital Limited as Corporate Adviser

Sativa Group Plc (AQSE: SATI), the UK’s leading quoted CBD wellness and medicinal cannabis Group, announces that it has appointed Peterhouse Capital Limited as its Corporate Adviser with immediate effect.
The Directors of the Company accept responsibility for the contents of this announcement.

Launch of cannabinoid cannabigerol (CBG) hand cleanser

Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, has commenced production of a cannabigerol (CBG) and alcohol-based hand cleanser in response to the increased need for hand sanitation as a result of Covid-19. Read more…

Comment on faster access for patients to cannabis-based medicinal products (CBMPs) following relaxation of import restrictions by the Department of Health and Social Care (DHSC) and the Home Office.

Yesterday the Department of Health and Social Care (DHSC) and the Home Office announced that patients will be able to get faster access to cannabis-based medicinal products (CBMPs) through the relaxation of import restrictions. Sativa welcomes this initiative as it endorses the Group’s view that the UK is fast-developing as a significant medicinal cannabis market… Read more